BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12694758)

  • 1. Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance.
    Sienel W; Seen-Hibler R; Mutschler W; Pantel K; Passlick B
    Eur J Cardiothorac Surg; 2003 Apr; 23(4):451-6. PubMed ID: 12694758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of tumour vessel invasion in determining the morphology of isolated tumour cells in the pulmonary vein in non-small-cell lung cancer.
    Funaki S; Sawabata N; Abulaiti A; Nakagiri T; Shintani Y; Inoue M; Minami M; Okumura M
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1126-30. PubMed ID: 23100289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis.
    Izbicki JR; Passlick B; Hosch SB; Kubuschock B; Schneider C; Busch C; Knoefel WT; Thetter O; Pantel K
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):623-30. PubMed ID: 8800148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer.
    Kubuschok B; Passlick B; Izbicki JR; Thetter O; Pantel K
    J Clin Oncol; 1999 Jan; 17(1):19-24. PubMed ID: 10458213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer.
    Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsubota N; Tsujimura T; Tabata C; Nakano T; Hasegawa S
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):775-83. PubMed ID: 24618055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood.
    Franco R; Pirozzi G; Scala S; Cantile M; Scognamiglio G; Camerlingo R; Botti G; Rocco G
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):368-75. PubMed ID: 21683606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer.
    Rud AK; Boye K; Fodstad Ø; Juell S; Jørgensen LH; Solberg S; Helland Å; Brustugun OT; Mælandsmo GM
    Diagn Pathol; 2016 Jun; 11(1):50. PubMed ID: 27316334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.
    Ge MJ; Shi D; Wu QC; Wang M; Li LB
    J Cancer Res Clin Oncol; 2006 Apr; 132(4):248-56. PubMed ID: 16320073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the sequence of pulmonary vasculature ligation have any oncological impact during an anatomical lung resection for non-small-cell lung cancer?
    Toufektzian L; Attia R; Polydorou N; Veres L
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):260-4. PubMed ID: 25355664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.
    Funaki S; Sawabata N; Nakagiri T; Shintani Y; Inoue M; Kadota Y; Minami M; Okumura M
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):322-7. PubMed ID: 21215651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung excision of non-small-cell lung cancer leaves cancer cells in residual lobe: cytological detection using pulmonary vein blood.
    Sawabata N; Funaki S; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):131-5. PubMed ID: 26538102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage.
    Ichinose Y; Yano T; Asoh H; Yokoyama H; Yoshino I; Katsuda Y
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):601-5. PubMed ID: 7564425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.
    Rena O; Boldorini R; Papalia E; Turello D; Massera F; Davoli F; Roncon A; Baietto G; Casadio C
    Ann Thorac Surg; 2014 Mar; 97(3):987-92. PubMed ID: 24480258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
    Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
    J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer.
    Sienel W; Hellers J; Morresi-Hauf A; Lichtinghagen R; Mutschler W; Jochum M; Klein C; Passlick B; Pantel K
    Int J Cancer; 2003 Feb; 103(5):647-51. PubMed ID: 12494473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
    Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
    Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.